Discover 1,307 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,307
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
for
Low Risk Myelodysplastic Syndromes
Location: Columbus OH, Cleveland OH, Durham NC, St Louis MO,
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05308264
Phase 1, Phase 2, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Columbus OH, Cincinnati OH, West Chester OH, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase 1, Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Location: Columbus OH, Washington D.C. DC, Richmond VA, Derby CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06465316
Phase 1, Recruiting
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
for
Breast Cancer
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT04022616
Recruiting
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
for
Advanced Malignant Solid Neoplasm,
Location: Columbus OH, Bethesda MD, New York NY, Mineola NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687136
Phase 1, Recruiting
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Columbus OH, Richmond VA, Minneapolis MN
Sponsor: Yazeed Sawalha
Sex: All
Age: 18+
Code: NCT06536049
Phase 1, Phase 2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Columbus OH, Ypsilanti MI, Canton MI, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Columbus OH, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase 2, Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Columbus OH, Toronto, Nashville TN, Boston MA,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06827613
Phase 1, Phase 2, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Columbus OH, Indianapolis IN, Chicago IL,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase 2, Recruiting
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
for
B-Cell Non-Hodgkin Lymphoma-Recurrent,
Location: Columbus OH
Sponsor: Nathan Denlinger
Sex: All
Age: 18+
Code: NCT06209619
Phase 1, Recruiting
Informing Oral Nicotine Pouch Regulations to Promote Public Health
for
Tobacco-Related Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 21+
Code: NCT06315881
Phase 2, Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Columbus OH, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
for
NSCLC, Stage I
Location: Columbus OH, Indianapolis IN, Charlottesville VA,
Sponsor: Greg Durm, MD
Sex: All
Age: 18+
Code: NCT04317534
Phase 2, Recruiting
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction
for
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center